CBC and CBG had strong binding to glioblastoma targets and killed brain cancer cells across multiple cell lines.
Neuro-oncology researchers, cannabinoid pharmacologists, and cancer research enthusiasts.
What the researchers found
CBC, CBG, and CBD demonstrated strong binding to GPR55 and PINK1 glioblastoma targets. Confirmed cytotoxic effects on glioblastoma cell lines. Differential GPR55/PINK1 expression in tumor vs. normal tissue.
Why it matters
Glioblastoma has median survival of 15 months. Minor cannabinoids may offer new therapeutic avenues.
The numbers in context
Three glioblastoma cell lines tested. Strong binding to GPR55 and PINK1. All three cannabinoids showed cytotoxic effects.
How the study worked
Molecular docking, cell viability assays on multiple brain cancer cell lines, plus transcriptomic analysis.
What this study cannot tell us
In vitro only. Blood-brain barrier not addressed. No comparison with standard treatments.
How to read the evidence
Multi-method approach but in vitro only.
When this study was published
2025 in silico to in vitro study of minor cannabinoids against glioblastoma.
The bigger picture
CBC and CBG deserve attention alongside THC and CBD in cancer research, with GPR55 and PINK1 as targetable pathways.
Questions still open
- Could CBC or CBG cross the blood-brain barrier?
- Would combining with temozolomide improve outcomes?
Common questions
Can cannabinoids fight brain cancer?
What are CBC and CBG?
Read the original research
Evaluating the Antitumor Potential of Cannabichromene, Cannabigerol, and Related Compounds from Cannabis sativa and Piper nigrum Against Malignant Glioma: An In Silico to In Vitro Approach.
International journal of molecular sciences, 26(12)
Citation
Turizo Smith, Andrés David; Montoya Moreno, Nicolás; Rodríguez-García, Josefa Antonia; Marín-Loaiza, Juan Camilo; Arboleda Bustos, Gonzalo. (2025). Evaluating the Antitumor Potential of Cannabichromene, Cannabigerol, and Related Compounds from Cannabis sativa and Piper nigrum Against Malignant Glioma: An In Silico to In Vitro Approach.. International journal of molecular sciences, 26(12). https://doi.org/10.3390/ijms26125688
Explore the wider topic
- CBD Oil Quality Guide: How to Avoid Snake Oil
- Anxiety After Quitting Weed: When to Consider Medication
- Cannabis for Chemotherapy Nausea: What the Evidence Actually Shows
- Cannabis for Chronic Pain: What the Research Actually Supports
- Cannabis and Epilepsy: The Epidiolex Story and What It Means
- Does CBD Actually Work for Anxiety? What the Evidence Shows
- Does CBD Help with Weed Withdrawal? What Studies Show
- CBD vs THC: The Differences That Actually Matter
- The Proven Medical Benefits of Cannabis: What Research Supports
- Quitting Weed Before Surgery
- Weed and Medications: What Changes When You Quit
- Quitting Weed During Pregnancy: What You Need to Know
- Quitting Weed While Pregnant: What You Need to Know
- Cannabis and Older Adults: Risks Seniors Should Know
- Cannabis and Breastfeeding: THC in Breast Milk